This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Reddy, B. S. Articles by El-Bayoumy, K. Search for Related Content PubMed PubMed Citation Articles by Reddy, B. S. Articles by El-Bayoumy, K.

Chemoprevention of Colon Carcinogenesis by the Synthetic Organoselenium Compound 1,4-Phenylenebis(methylene)selenocyanate¹

Divisions of Nutritional Carcinogenesis [B. S. R., N. K.], Experimental Pathology and Toxicology [A. R.], and Chemical Carcinogenesis [P. U., K. E-B.], American Health Foundation, Valhalla, New York 10595

The chemopreventive effect of 40% and 80% maximum tolerated dose (MTD) levels of 1,4-phenylenebis(methylene)selenocyanate (p-XSC) administered in the diet during the initiation phase (2 weeks before, during, and up to 3 days after carcinogen administration) and the post-initiation phase (3 days after carcinogen treatment until termination) of azoxymethane (AOM)-induced colon carcinogenesis was studied in male F344 rats. The MTD of p-XSC was determined in male F344 rats and found to be 50 ppm. Beginning at 5 weeks of age, all animals were divided into various experimental groups (42 rats/group) and fed the high-fat semipurified diet or diets containing 20 (40% MTD) and 40 (80% MTD) ppm p-XSC. At 7 weeks of age, all animals (30 rats/group) except the vehicle-treated groups (12 rats/group) were administered s.c. injections of AOM (15 mg/kg body weight/week for 2 weeks). Three days after the second injection of AOM or vehicle (normal saline), groups of animals fed the p-XSC diets and control diet were transferred, respectively, to control diet and p-XSC diets and continued on these diets until the termination of the study. All animals were necropsied during the 36th week after AOM treatment. Colonic mucosal prostaglandin E₂ and selenium-dependent glutathione peroxidase were measured in animals fed the control and p-XSC diets at the termination of the study. The results indicate that 40 ppm p-XSC administered during the initiation phase significantly inhibited the colon tumor incidence (percentage of animals with tumors). Dietary p-XSC administered at 20 and 40 ppm levels during the initiation phase significantly inhibited colon tumor multiplicity (tumors/animal and tumors/tumor-bearing animal). Colon tumor incidence and multiplicity were significantly reduced in groups fed 20 and 40 ppm p-XSC diets at the postinitiation phase of carcinogenesis. Colonic mucosal selenium-dependent glutathione peroxidase activity was increased, and prostaglandin E₂ was reduced in animals fed the p-XSC diet compared to animals fed the control diet. Whereas the precise mechanisms of p-XSC-induced inhibition of colon carcinogenesis remain to be elucidated, it is likely that the effect during the initiation and postinitiation phases may be due to alteration in carcinogen metabolism and to modulation of prostaglandin synthesis and selenium-dependent glutathione peroxidase activity.

¹ Supported by USPHS Grants CA17613 and CA46589 from the National Cancer Institute. This paper is fourteenth in the series "Selenium in Chemoprevention of Carcinogenesis."

² To whom requests for reprints should be addressed at the Division of Nutritional Carcinogenesis, American Health Foundation, One Dana Road, Valhalla, NY 10595.

Received 4/ 2/92. Accepted 8/10/92.

This article has been cited by other articles:

				B. A. Narayanan, N. K. Narayanan, D. Desai, B. Pittman, and B. S. Reddy Effects of a combination of docosahexaenoic acid and 1,4-phenylene bis(methylene) selenocyanate on cyclooxygenase 2, inducible nitric oxide synthase and {beta}-catenin pathways in colon cancer cells Carcinogenesis, December 1, 2004; 25(12): 2443 - 2449. [Abstract] [Full Text] [PDF]

				A. Ghose, J. Fleming, K. El-Bayoumy, and P. R. Harrison Enhanced Sensitivity of Human Oral Carcinomas to Induction of Apoptosis by Selenium Compounds: Involvement of Mitogen-activated Protein Kinase and Fas Pathways Cancer Res., October 1, 2001; 61(20): 7479 - 7487. [Abstract] [Full Text] [PDF]

				C. V. Rao, C-Q. Wang, B. Simi, J. G. Rodriguez, I. Cooma, K. El-Bayoumy, and B. S. Reddy Chemoprevention of Colon Cancer by a Glutathione Conjugate of 1,4-Phenylenebis(methylene)selenocyanate, a Novel Organoselenium Compound with Low Toxicity Cancer Res., May 1, 2001; 61(9): 3647 - 3652. [Abstract] [Full Text]

				C. V. Rao, I. Cooma, J. G.R. Rodriguez, B. Simi, K. El-Bayoumy, and B. S. Reddy Chemoprevention of familial adenomatous polyposis development in the APCmin mouse model by 1,4-phenylene bis(methylene)selenocyanate Carcinogenesis, April 1, 2000; 21(4): 617 - 621. [Abstract] [Full Text] [PDF]

				B. S. Reddy Novel Approaches to the Prevention of Colon Cancer by Nutritional Manipulation and Chemoprevention Cancer Epidemiol. Biomarkers Prev., March 1, 2000; 9(3): 239 - 247. [Abstract] [Full Text]

				O. S. Sohn, E. S. Fiala, P. Upadhyaya, Y.-H. Chae, and K. El-Bayoumy Comparative effects of phenylenebis(methylene)selenocyanate isomers on xenobiotic metabolizing enzymes in organs of female CD rats Carcinogenesis, April 1, 1999; 20(4): 615 - 621. [Abstract] [Full Text] [PDF]

				C. Ip Lessons from Basic Research in Selenium and Cancer Prevention J. Nutr., November 1, 1998; 128(11): 1845 - 1854. [Abstract] [Full Text]